James F. Young, a Director of Novavax Inc, has filed to sell 10,000 shares of common stock on December 24, 2024. The aggregate market value of the shares to be sold is $84,800, with an estimated price of $8.48 per share.The shares to be sold were acquired through stock plan activities over the past three years. Young received 4,600 shares on June 10, 2023, 1,400 shares on June 17, 2022, and 4,000 shares on July 1, 2021, all from the issuer. The transaction is yet to be completed, with the notice date being January 2, 2025.No securities have been sold by Young in the past three months prior to this announcement. This planned sale represents a significant portion of the stock acquired by the director through recent stock plan activities.

James F. Young, a Director of Novavax Inc, has filed to sell 10,000 shares of common stock on December 24, 2024. The aggregate market value of the shares to be sold is $84,800, with an estimated price of $8.48 per share.The shares to be sold were acquired through stock plan activities over the past three years. Young received 4,600 shares on June 10, 2023, 1,400 shares on June 17, 2022, and 4,000 shares on July 1, 2021, all from the issuer. The transaction is yet to be completed, with the notice date being January 2, 2025.No securities have been sold by Young in the past three months prior to this announcement. This planned sale represents a significant portion of the stock acquired by the director through recent stock plan activities.